COVID-19

The results were compared to those in the previous Pfizer-BioNTech study in people between 16 and 25 years of age who were immunized with 30 μg doses.

Co-administration of COVID-19 vaccines and flu vaccines is also available.

The COVID-19 booster doses are to be administered at least 6 months after completion of the primary 2-dose series and are the same formulation and dosage strength as the original doses.

Remdesivir demonstrated a statistically significant 87% reduction in risk for the composite primary endpoint of COVID-19-related hospitalization or all-cause death by day 28.

It demonstrated 93.2% efficacy 14 days afterward and greater than 90% for 4 or more months.

In part 2 of their discussion on COVID-19 vaccine mandates, experts Ned Milenkovich, PharmD, and Ron Lanton III, Esq., discussed how provider status could impact potential legal issues around COVID-19 vaccine mandates.

These patients had comparable levels of antibodies to individuals without the disease after a 2-dose course of the vaccination.

With the recent announcement of federal COVID-19 vaccine mandates, in addition to private businesses potentially requiring vaccines for employees, pharmacies and other health care facilities could have questions about legal issues surrounding these mandates.

Stanford research results show that of nearly 39,000 individuals, just 22 had potential allergic reactions, and all recovered.

The results are the first from a pivotal trial of any COVID-19 vaccine in children under 12 years of age, with results in children under 5 years of age expected as soon as later this year.

Sophia Humphreys, PharmD, MHA, said data are continuing to evolve around the safety and recommendations of COVID-19 booster doses, especially for the vaccine from Pfizer and BioNTech.

Pharmacists will need to make sure they have the necessary personal protective equipment in place to meet increased clinic activity and while keeping an eye on levels of flu vaccines and tests.

Integrating these facilities into the pharmacy supply chain strategy has become key for hospitals during the pandemic.

The panel did, however, vote to recommend the booster shots to adults over 65 years of age and those at high risk of severe COVID-19.

The results of a review by Murdoch Children’s Research Institute finds that pediatric patients who are vaccinated get protection from the long-term effects of the disease.

Investigators at the IMT School for Advanced Studies say that future rollouts should focus on workers, which would help avoid another lockdown.

Strong immune memory lasted in all age groups tested after receiving the Moderna vaccine, including individuals over 70 years of age who are especially vulnerable to COVID-19.

Recent study results show that vitamin D may offer protection against critical disease and death.

The National Institutes of Health’s studies aim to research the long-term effects of the coronavirus.

Investigators said that NanoSTING, can be shipped and stored without the need for freezing for up to 11 months.

Jason Ausili, PharmD, the Chief Clinical Officer of FDS Amplicare, discusses the impact on community pharmacies and patients of the recent announcement by the HHS regarding the amendment to the COVID-19 PREP Act.

New research results show that patients with mild coronavirus produce antibodies that are able neutralize the infection.

Customers vaccinated at any Rite Aid location can supplement their paper vaccination card with a verified digital version that can be accessed on their mobile device.

Individuals who had depression or stress in a hospital in Mexico were also 4.5 and 3.18 times more likely, respectively, to experience delays in treatment.

Study results show that individuals who are unvaccinated are 5 to 7 times more likely to seek medical care because of the predominant strain of the coronavirus.

Pharmacists can review clinical evidence and CDC recommendations before providing information.

But will policy and program administrators make optimal use of existing primary care and pharmacy systems?

These special immune system defense molecules help show which individuals are most at risk of needing intensive care and need to be monitored more closely, new study results show.

Results of a new study show that the vaccines seldomly reach the area that were heavily affected by the pandemic, because of ethnic, racial, and socioeconomic disparities.

The results of a new study show that when coronavirus-infected diabetic mice were injected with an interferon beta, SETDB2 increased and helped decrease the inflammatory cytokines.